The combined use of electroconvulsive therapy and antipsychotics in patients with schizophrenia

Journal of ECT

Volumn 21, Issue 2, 2005, Pages 75-83

  Braga, Raphael J ^a   Petrides, Georgios ^a,b  

^a ZUCKER HILLSIDE HOSPITAL   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Antipsychotics; Augmentation; Efficacy; Electroconvulsive therapy; Safety; Schizophrenia

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; FLUPENTIXOL; FLUPHENAZINE; HALOPERIDOL; LOXAPINE; NEUROLEPTIC AGENT; PERPHENAZINE; PIMOZIDE; PSYCHOTROPIC AGENT; RISPERIDONE; TIOTIXENE; TRIFLUOPERAZINE;

CLINICAL TRIAL; DRUG EFFICACY; ELECTROCONVULSIVE THERAPY; HUMAN; MEDLINE; MOTOR DYSFUNCTION; OPEN STUDY; PARKINSONISM; REVIEW; SAFETY; SCHIZOPHRENIA; TARDIVE DYSKINESIA;

ANTIPSYCHOTIC AGENTS; ELECTROCONVULSIVE THERAPY; HUMANS; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 20444382433     PISSN: 10950680     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.yct.0000165500.60784.05     Document Type: Review

References (69)

1. Cornblatt BA, Green MF, Walker EF. Schizophrenia: etiology and neurocognition. In: Millon T, Blaneyu PH, Davis R, eds. Oxford Textbook of Psychopathology. New York: Oxford University Press, 1999:277-310.
2. Conley RR, Buchanan RW. Evaluation of treatment-resistant schizophrenia. Schizophr Bull. 1997;23:663-674.
3. Kane JM. Management strategies for the treatment of schizophrenia. J Clin Psychiatry. 1999;60(Suppl 12):13-17.
4. Baker AA, Bird G, Lavin NI, et al. E.C.T. in schizophrenia. J Ment Sci. 1960;106:1506-1511.
5. Langsley DG, Enterline JD, Hickerson GX Jr. A comparison of chlorpromazine and EST in treatment of acute schizophrenic and manic reactions. AMA Arch Neurol Psychiatry. 1959;81:384-391.
6. Miller AL, Hall CS, Buchanan RW, et al. The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update. J Clin Psychiatry. 2004;65:500-508.
7. Tharyan P, Adams CE. Electroconvulsive therapy for schizophrenia. Cochrane Database Syst Rev. 2002; CD000076.
8. Taylor P, Fleminger JJ. ECT for schizophrenia. Lancet. 1980;1:1380-1382.
9. Luria RE, McHugh PR. Reliability and clinical utility of the "Wing" Present State examination. Arch Gen Psychiatry. 1974;30:866-871.
10. Asberg M, Schalling D. Construction of a new psychiatric rating instrument, the Comprehensive Psychopathological Rating Scale (CPRS). Prog Neuropsychopharmacol. 1979;3:405-412.
11. Brandon S, Cowley P, McDonald C, et al. Leicester ECT trial: results in schizophrenia. Br J Psychiatry. 1985;146:177-183.
12. Montgomery SA, Taylor P, Montgomery D. Development of a schizophrenia scale sensitive to change. Neuropharmacology. 1978;17:1061-1063.
13. Agarwal AK, Winny GC. Role of ECT phenotiazine combination in schizophrenia. Indian J Psychiatry. 1985;27:233-236.
14. Woerner MG, Mannuzza S, Kane JM. Anchoring the BPRS: an aid to improved reliability. Psychopharmacol Bull. 1988;24:112-117.
15. Abraham KR, Kulhara P. The efficacy of electroconvulsive therapy in the treatment of schizophrenia. A comparative study. Br J Psychiatry. 1987; 151:152-155.
16. Spitzer RL, Endicott J, Robins E. Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry. 1978;35:773-782.
17. Guy W. ECDEU Assessment Manual for Psychopharmacology. Washington, DC: U.S. Department of Health, Education and Welfare Publication; 1976.
18. Sarkar P, Andrade C, Kapur B, et al. An exploratory evaluation of ECT in haloperidol-treated DSM-IIIR schizophreniform disorder. Convuls Ther. 1994;10:271-278.
19. Sarita EP, Janakiramaiah N, Gangadhar BN, et al. Efficacy of Combined ECT after Two Weeks of Neuroleptics in Schizophrenia: A Double Blind Controlled Study. Nimhans J. 1998;16:243-251.
20. Ukpong DI, Makanjuola RO, Morakinyo O. A controlled trial of modified electroconvulsive therapy in schizophrenia in a Nigerian teaching hospital. West Afr J Med. 2002;21:237-240.
21. Andreasen NC. Scale for the Assessment of Negative Symptoms. Iowa City, IA: University of Iowa; 1984.
22. Small JG, Milstein V, Klapper M, et al. ECT combined with Neuroleptics in the Treatment of Schizophrenia. Psychopharmacol Bull. 1982;18:34-35.
23. Feighner JP, Robins E, Guze SB, et al. Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry. 1972;26:57-63.
24. Janakiramaiah N, Channabasavanna SM, Murthy NS. ECT/chlorpromazine combination versus chlorpromazine alone in acutely schizophrenic patients. Acta Psychiatr Scand. 1982;66:464-470.
25. Chanpattana W, Chakrabhand ML, Sackeim HA, et al. Continuation ECT in treatment-resistant schizophrenia: a controlled study. J ECT. 1999; 15:178-192.
26. Kane J, Honigfeld G, Singer J, et al. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry. 1988;45:789-796.
27. Miller DD, Perry PJ, Cadoret RJ, et al. Clozapine's effect on negative symptoms in treatment-refractory schizophrenics. Compr Psychiatry. 1994;35:8-15.
28. Chanpattana W, Chakrabhand ML, Kongsakon R, et al. Short-term effect of combined ECT and neuroleptic therapy in treatment-resistant schizophrenia. J ECT. 1999;15:129-139.
29. Chanpattana W, Buppanharun W, Raksakietisak S, et al. Seizure threshold rise during electroconvulsive therapy in schizophrenic patients. Psychiatry Res. 2000;96:31-40.
30. Chanpattana W. Maintenance ECT in treatment-resistant schizophrenia. J Med Assoc Thai. 2000;83:657-662.
31. Chanpattana W, Chakrabhand ML. Combined ECT and neuroleptic therapy in treatment-refractory schizophrenia: prediction of outcome. Psychiatry Res. 2001;105:107-115.
32. Chanpattana W, Chakrabhand ML. Factors influencing treatment frequency of continuation ECT in schizophrenia. J ECT. 2001;17:190-194.
33. Chanpattana W, Kramer BA. Acute and maintenance ECT with flupenthixol in refractory schizophrenia: sustained improvements in psychopathology, quality of life, and social outcomes. Schizophr Res. 2003;63:189-193.
34. Das PS, Saxena S, Mohan D, et al. Adjunctive electroconvulsive therapy for schizophrenia. Natl Med J India. 1991;4:183-184.
35. Dodwell D, Goldberg D. A study of factors associated with response to electroconvulsive therapy in patients with schizophrenic symptoms. Br J Psychiatry. 1989;154:635-639.
36. Friedel RO. The combined use of neuroleptics and ECT in drug resistant schizophrenic patients. Psychopharmacol Bull. 1986;22:928-930.
37. Gujavarty K, Greenberg LB, Fink M. Electroconvulsive therapy and neuroleptic medication in therapy-resistant positive-symptom psychosis. Convuls Ther. 1987;3:185-195.
38. Hirose S, Ashby CR Jr, Mills MJ. Effectiveness of ECT combined with risperidone against aggression in schizophrenia. J ECT. 2001;17:22-26.
39. Konig P, Glatter-Gotz U. Combined electroconvulsive and neuroleptic therapy in schizophrenia refractory to neuroleptics. Schizophr Res. 1990; 3:351-354.
40. Kramer BA. ECT in elderly patients with schizophrenia. Am J Geriatr Psychiatry. 1999;7:171-174.
41. Milstein V, Small JG, Miller MJ, et al. Mechanisms of action of ECT: schizophrenia and schizoaffective disorder. Biol Psychiatry. 1990;27: 1282-1292.
42. Nahshoni E, Manor N, Bar F, et al. Alterations in QT dispersion in medicated schizophrenia patients following electroconvulsive therapy. Eur Neuropsychopharmacol. 2004;14:121-125.
43. Natani GD, Gautam S, Gehlot PS. Comparison of three treatment regimes in schizophrenia. Indian J Psychiatry. 1983;25:306-311.
44. Sajatovic M, Meltzer HY. The effect of short-term electroconvulsive treatment plus neuroleptics in treatment-resistant schizophrenia and schizoaffective disorder. Convuls Ther. 1993;9:167-175.
45. Tang WK, Ungvari GS. Efficacy of electroconvulsive therapy combined with antipsychotic medication in treatment-resistant schizophrenia: a prospective, open trial. J ECT. 2002;18:90-94.
46. Rockland LH, Pollin W. Quantification of psychiatric mental status, for use with psychotic patients. Arch Gen Psychiatry. 1965;12:23-28.
47. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: 1987.
48. Folstein MF, Holstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
49. Reitan RM. Problems and prospects in studying the psychological correlates of brain lesions. Cortex. 1966;2:127-154.
50. Rami L, Bernardo M, Valdes M, et al. Absence of additional cognitive impairment in schizophrenia patients during maintenance electroconvulsive therapy. Schizophr Bull. 2004;30:185-189.
51. Bagadia VN, Abhyankar R, Pradhan PV, et al. Reevaluation of ECT in schizophrenia: right temporoparietal versus bitemporal electrode placement. Convuls Ther. 1988;4:215-220.
52. Mukherjee S, Debsikdar V. Absence of neuroleptic-induced parkinsonism in psychotic patients receiving adjunctive electroconvulsive therapy. Convuls Ther. 1994;10:53-58.
53. Chanpattana W, Chakrabhand ML, Buppanharun W, et al. Effects of stimulus intensity on the efficacy of bilateral ECT in schizophrenia: a preliminary study. Biol Psychiatry. 2000;48:222-228.
54. Masiar SJ, Johns CA. ECT following clozapine. Br J Psychiatry. 1991; 158:135-136.
55. Bloch Y, Pollack M, Mor I. Should the administration of ECT during clozapine therapy be contraindicated? Br J Psychiatry. 1996;169:253-254.
56. Benatov R, Sirota P, Megged S. Neuroleptic-resistant schizophrenia treated with clozapine and ECT Convuls Ther. 1996;12:117-121.
57. Bhatia SC, Bhatia SK, Gupta S. Concurrent administration of clozapine and ECT: a successful therapeutic strategy for a patient with treatment-resistant schizophrenia. J ECT. 1998;14:280-283.
58. Dean CE. Severe self-injurious behavior associated with treatment-resistant schizophrenia: treatment with maintenance electroconvulsive therapy. J ECT. 2000;16:302-308.
59. Husni M, Haggarty J, Peat C. Clozapine does not increase ECT-seizure duration. Can J Psychiatry. 1999;44:190-191.
60. Safferman AZ, Munne R. Combining clozapine with ECT. Convuls Ther. 1992;8:141-143.
61. Frankenburg FR, Suppes T, McLean PE. Combined clozapine and electroconvulsive therapy. Convuls Ther. 1993;9:176-180.
62. Cardwell BA, Nakai B. Seizure activity in combined clozapine and ECT: a retrospective view. Convuls Ther. 1995;11:110-113.
63. Kales HC, Dequardo JR, Tandon R. Combined electroconvulsive therapy and clozapine in treatment-resistant schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 1999;23:547-556.
64. James DV, Gray NS. Elective combined electroconvulsive and clozapine therapy. Int Clin Psychopharmacol. 1999;14:69-72.
65. Kho KH, Blansjaar BA, de Vries S, et al. Electroconvulsive therapy for the treatment of clozapine nonresponders suffering from schizophrenia - an open label study. Eur Arch Psychiatrv Clin Neurosci. 2004;254: 372-379.
66. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.L): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22-33.
67. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261-276.
68. Beale MD, Pritchett JT, Kellner CH. Supraventricular tachycardia in a patient receiving ECT, clozapine, and caffeine. Convuls Ther. 1994;10: 228-231.
69. Salzman C. ECT, research, and professional ambivalence. Am J Psychiatry. 1998;155:1-2.